Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-05-23
1988-10-04
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 82, 544126, 544361, 514253, 5142328, C07D47104, C07D41314, C07D40114, A61K 3147
Patent
active
047756748
ABSTRACT:
Novel series of 2,3-dihydro-2-oxo-1H-imidazo[4,5-b]quinolinyl ether derivatives of formula ##STR1## wherein R.sub.1 is hydrogen, lower alkly, benzyl; R.sub.2 is hydrogen, halogen, lower alkyl, lower alkoxy; Alk is alkylene; Y is hydroxy and alkanoic or aralkanoic esters thereof, oxo ketone, dialkylamino, carboxylic acid and esters, carboxamides, alkoxy, ethanolamines and cyclic carbamates thereof, tetrazolyl, and optionally substituted phenylsulfonyl. The compounds are cyclic AMP phosphodiesterase inhibitors and are particularly useful as inhibitors of blood platelet aggregation and/or as cardiotonic agents.
REFERENCES:
patent: 3932407 (1976-01-01), Beverung, Jr. et al.
patent: 4256748 (1981-03-01), Chodnekar et al.
patent: 4490371 (1984-12-01), Jones et al.
Kozak, et al., Bull. Intern. Acad. Polanaise, 1930A, 432-438 (Chem. Abs., 25, 5400).
Musial, Roczniki Chem., 1951, 25, 46-52 (Chem. Abs., 1953, 47, 4885f).
Fryer, et al., J. Org. Chem., 1977, 42, 2212-2219.
Reid, et al., Chem. Ber., 1956, 89 2684-2687.
Fleming et al., New Drugs Annual: Cardiovascular Drugs, Raven Press, pp. 277-294, New York (1983).
Meanwell Nicholas A.
Wright John J.
Bristol-Myers Company
Lee Mary C.
Northington Zinna
Uloth Robert H.
LandOfFree
Imidazoquinolinylether derivatives useful as phosphodiesterase a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoquinolinylether derivatives useful as phosphodiesterase a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoquinolinylether derivatives useful as phosphodiesterase a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2156581